Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

The Ozempic performance meant that, overall, Novo Nordisk's revenue growth was ... to $1.3 billion after it missed the mark in a chronic kidney disease (CKD) trial. Discover how AI is transforming ...

Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good day, and thank you for standing by. Welcome to the Third Quarter 2024 Novo Nordisk A/S Earnings Conference Call. At this time, all ...

Novo Nordisk, the maker of Ozempic ... suggests potential benefits of semaglutide in reducing risks of conditions like ...

Novo Nordisk has agreed ... showing that its Wegovy and Ozempic drugs – both based on GLP-1 agonist semaglutide – can reduce cardiovascular and kidney disease outcomes, respectively, in ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

According to a March 2023 study from the Bank of America Institute about consumer spending, seniors born in 1964 or earlier ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...